Why it matters
The pharmaceuticals context.
Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.
Project record
At a glance
- Company
- Organogenesis
- Industry
- Pharmaceuticals
- Location
- Smithfield, Rhode Island
- Investment
- $97.5M
- Permanent jobs announced
- 103
- Status
- Under Construction
- Announced
- Nov 22, 2024
- Opening timeline
- Not yet announced
- Added to tracker
- Aug 14, 2026
Sources
Official references
- Rhode Island incentive approval https://eoc.ri.gov/press-releases/rhode-island-commerce-board-approves-incentive-package-regenerative-medicine-company
- Company project announcement https://www.organogenesis.com/pdf/100_Tech_Way_Release_May_2025_FINAL.pdf
- Current company project page https://www.organo-ri.com/
- Construction evidence https://www.thedaviscompanies.com/davis-executes-full-building-lease-agreement-with-oranogenesis-at-premier-biomanufacturing/
Related
Other projects to know
Back to the tracker/projects/organogenesis-smithfield-biomanufacturing-facility